Cargando…

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension

We compared the efficacy and safety of third‐standard‐dose triple and third‐standard‐dose dual antihypertensive combination therapies in patients with mild to moderate hypertension. This was a phase II multicenter, randomized, double‐blind, parallel‐group trial. After a 4‐week placebo run‐in period,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Ki‐Chul, Hong, Soon Jun, Rhee, Moo‐Yong, Jeong, Myung‐Ho, Kim, Dae‐Hee, Lim, Sang‐Wook, Park, Kyungil, Lee, Jin Bae, Kim, Seok‐Yeon, Cho, Jin‐Man, Cho, Goo‐Yeong, Heo, Jung‐Ho, Kim, Sang‐Hyun, Lee, Hae‐Young, Kim, Weon, Cho, Deok‐Kyu, Park, Sungha, Shin, Jinho, Pyun, Wook‐Bum, Kwon, Kihwan, Rha, Seung‐Woon, Jung, Jin‐A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Combination Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184484/ https://www.ncbi.nlm.nih.gov/pubmed/37095689 http://dx.doi.org/10.1111/jch.14656

Ejemplares similares

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
por: Lin, Junxiong, et al.
Publicado: (2023)

Age‐specific differences in hypertension combination management and associated factors influencing treatment choice
por: Xiong, Jianfei, et al.
Publicado: (2023)

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
por: Hong, Soon Jun, et al.
Publicado: (2020)

Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
por: Cho, In-Jeong, et al.
Publicado: (2021)

Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic
por: Shin, Jinho, et al.
Publicado: (2021)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial
por: Sung, Ki‐Chul, et al.
Publicado: (2022)

A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma
por: Chun, Jung Won, et al.
Publicado: (2022)

Dual Therapy Trial Using Esomeprazole and Amoxicillin as Third-line Rescue Therapy for Helicobacter pylori Infection
por: Park, Hyun Kyung, et al.
Publicado: (2011)

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
por: Lee, Nuri, et al.
Publicado: (2022)

Comprehensive Application of the International Classification of Headache Disorders Third Edition, Beta Version
por: Kim, Byung-Kun, et al.
Publicado: (2016)

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Activation of WNT/β‐catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
por: Park, Ye‐Lim, et al.
Publicado: (2018)

Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases
por: Lee, Jieun, et al.
Publicado: (2021)

Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?
por: Park, Sungha, et al.
Publicado: (2020)

Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study
por: Kang, Ji-Man, et al.
Publicado: (2023)

Efficacy and safety of silodosin in the treatment of lower urinary tract symptoms in elderly men taking antihypertensive medications
por: Choi, Woo Suk, et al.
Publicado: (2017)

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)
por: Kim, Kyung‐Jin, et al.
Publicado: (2016)

Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters
por: Jung, Jinhong, et al.
Publicado: (2013)

Clinical features of chronic cluster headache based on the third edition of the International Classification of Headache Disorders: A prospective multicentre study
por: Cho, Soo-Jin, et al.
Publicado: (2019)

The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
por: Cho, Young-Rak, et al.
Publicado: (2011)

Perirenal Fat and Kidney Function Deterioration in Patients With Acute Decompensated Heart Failure
por: Cho, In-Jeong, et al.
Publicado: (2023)

Cyberknife Dosimetric Planning Using a Dose-Limiting Shell Method for Brain Metastases
por: Yoon, Kyoung Jun, et al.
Publicado: (2018)

Suboptimal Management Status of Younger Hypertensive Population in Korea
por: Lee, Hae-Young, et al.
Publicado: (2021)

Development of CT Effective Dose Conversion Factors from Clinical CT Examinations in the Republic of Korea
por: Lee, Sang-Kyung, et al.
Publicado: (2020)

Spontaneous Involution of Rathke’s Cleft Cysts without Visual Symptoms
por: Kim, Chang-Wook, et al.
Publicado: (2016)

Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension
por: Lee, Hae Young, et al.
Publicado: (2021)

SARS-CoV-2 Antibody Response and Sustainability after a Third Dose of BNT162b2 in Healthcare Workers at Health Promotion Centers
por: Nah, Eun-Hee, et al.
Publicado: (2023)

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
por: Kim, Hyeon Chang, et al.
Publicado: (2019)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Kim, Kwang-il, et al.
Publicado: (2019)

Significance of Pseudo-Conductive Hearing Loss and Positional Nystagmus for Perilymphatic Fistula: Are They Related to Third-Window Effects?
por: Kim, Jong Sei, et al.
Publicado: (2021)

Characteristics of bony changes and tooth displacement in the mandibular cystic lesion involving the impacted third molar
por: Lee, Jin-Hyeok, et al.
Publicado: (2014)

Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy
por: Kim, Se Hyun, et al.
Publicado: (2017)

Dose-Dependent Effects of Evening Primrose Oil in Children and Adolescents with Atopic Dermatitis
por: Chung, Bo Young, et al.
Publicado: (2013)

Zinc oxide nanoparticles: a 90-day repeated-dose dermal toxicity study in rats
por: Ryu, Hwa Jung, et al.
Publicado: (2014)

Evaluation of the Patient Effective Dose in Whole Spine Scanography Based on the Automatic Image Pasting Method for Digital Radiography
por: Kim, Jung-Su, et al.
Publicado: (2016)

Evaluation of delivered dose to a moving target by 4D dose reconstruction in gated volumetric modulated arc therapy
por: Chung, Hyekyun, et al.
Publicado: (2018)

Risk factors for postoperative infection of odontogenic cysts associated with mandibular third molar
por: Kim, Jin-woo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gsbicsd7bu6tn6tkle7sutddh6